DTL
PTCT icon

Dynamic Technology Lab’s PTC Therapeutics PTCT Stock Holding History

Dynamic Technology Lab’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,830
Closed -$261K – 1008
2026
Q1 		$261K Buy
+3,830
New +$271K 0.04% 658
2024
Q3 		– Sell
-17,328
Closed -$530K – 1280
2024
Q2 		$530K Buy
+17,328
New +$561K 0.06% 490
2022
Q4 		– Sell
-11,550
Closed -$580K – 1436
2022
Q3 		$580K Buy
+11,550
New +$566K 0.06% 578
2021
Q1 		– Sell
-4,539
Closed -$277K – 1430
2020
Q4 		$277K Buy
+4,539
New +$268K 0.04% 699
2018
Q3 		– Sell
-6,920
Closed -$233K – 1281
2018
Q2 		$233K Buy
+6,920
New +$216K 0.04% 792

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Dynamic Technology Lab's PTCT Position: Q2 2026 in Review

Dynamic Technology Lab sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 3,830 shares — an estimated $261K sold.

Dynamic Technology Lab first reported a position in PTCT in Q2 2018 and held it in 5 quarters. The position peaked at $580K in Q3 2022. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Dynamic Technology Lab reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 3,830 PTC Therapeutics shares in Q2 2026, an estimated $261K.
  • Dynamic Technology Lab first reported a position in PTC Therapeutics in Q2 2018 and held it in 5 quarters.
  • Dynamic Technology Lab's PTC Therapeutics position peaked at $580K in Q3 2022.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.